ESR1 and breast carcinoma: One study found the critical role of HER3 in the progression of breast cancer cells, whereas inhibition of HER3 expression reduces resistance to reversed anti-estrogen receptor (ER) tamoxifen resistance in breast cancer cell lines [101].